Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Immunisation, Lymphadenopathy
Clinical narrative: Fever; chills; swollen lymph nodes; pain and swelling at injection site; pain and swelling at injection site; tiredness; muscle and joint pain; muscle and joint pain; feeling unwell; booster; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 25 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Nov2021 12:00 (Lot number: FH8027) at the age of 25 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing), notes: Other medical history: IBS, asthma, allergies; "asthma" (unspecified if ongoing), notes: Other medical history: IBS, asthma, allergies; "allergies" (unspecified if ongoing), notes: Other medical history: IBS, asthma, allergies. Concomitant medication(s) included: SPIRONOLACTON; BUPROPION; SINGULAIR. Past drug history included: Ammoxicillin, reaction(s): "Known allergies: Ammoxicillin". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0171, Location of injection: Arm Left), administration date: 10Aug2021, when the patient was 25 years old, for COVID-19 immunization, reaction(s): "Dose 1: 01May2021, Dose 2: 10Aug2021"; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0150, Location of injection: Arm Left), administration date: 01May2021, when the patient was 25 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 22Nov2021, outcome "unknown", described as "booster"; PYREXIA (non-serious) with onset 22Nov2021 20:00, outcome "recovered" (2021), described as "Fever"; CHILLS (non-serious) with onset 22Nov2021 20:00, outcome "recovered" (2021), described as "chills"; LYMPHADENOPATHY (non-serious) with onset 22Nov2021 20:00, outcome "recovered" (2021), described as "swollen lymph nodes"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 22Nov2021 20:00, outcome "recovered" (2021) and all described as "pain and swelling at injection site"; FATIGUE (non-serious) with onset 22Nov2021 20:00, outcome "recovered" (2021), described as "tiredness"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 22Nov2021 20:00, outcome "recovered" (2021) and all described as "muscle and joint pain"; MALAISE (non-serious) with onset 22Nov2021 20:00, outcome "recovered" (2021), described as "feeling unwell". Therapeutic measures were not taken as a result of pyrexia, chills, lymphadenopathy, vaccination site pain, vaccination site swelling, fatigue, myalgia, arthralgia, malaise.  Additional information: The patient was not pregnant at time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19 was reported as no. Hospitalization prolonged was reported as no. The device date was on 24Nov2021.  Follow-up attempts are completed. No further information is expected.